Skip to main content

Rare Genetic Disorders

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

BioMarin Pharmaceutical
1 program
Collection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical ConditionsN/A1 trial
Active Trials
NCT02365376Unknown

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BioMarin PharmaceuticalCollection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions

Clinical Trials (1)

NCT02365376BioMarin PharmaceuticalCollection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions

Collection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions

Start: Jun 2013
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.